Skip to main content
. 2023 Mar 6;66(6):3968–3994. doi: 10.1021/acs.jmedchem.2c01905

Table 2. Inhibitory Activities of 7a against DNA Gyrase and Topo IV from S aureus, E. coli, A. baumannii, and P. aeruginosa.

 
IC50 [nM]a
enzyme 7a ciprofloxacin novobiocin
S. aureus DNA gyraseb 1.22 ± 0.04 12 170 ± 1 245 0.65 ± 0.03
  topo IVb 8.0 ± 1.2 6 075 ± 1 648 13 265 ± 7
E. coli DNA gyrasec <10 120 ± 20 170 ± 20
  topo IVc 44 ± 11 5 400 ± 2 100 11 000 ± 2 000
A. baumannii DNA gyraseb 2.42 ± 0.28 1 267 ± 344 2.17 ± 0.16
  topo IVb 119.7 ± 8.34 2 885 ± 332 9 465 ± 799
P. aeruginosa DNA gyrasec <10 ntd nt
  topo IVb 27.5 ± 16.3 3 895 ± 63.6 8 365 ± 445
a

IC50, concentration (mean ± SD of three independent experiments) that inhibits enzyme activity by 50%.

b

Tested in gel-based supercoiling (for DNA gyrase) and decatenation (for topo IV) assays.

c

Tested in supercoiling (for DNA gyrase) and relaxation (for topo IV) HTS assays.

d

nt, not tested.